We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The Royal Pharmaceutical Society (RPS) has called for changes to allow for the unrestricted, legitimate research of controlled drugs in response to a consultation from the Advisory Council on the Misuse of Drugs (ACMD).
Clinicians in the UK should have the option to prescribe cannabis-derived medicinal products where appropriate, drug experts have concluded, paving the way for laws prohibiting their use to be relaxed.